Genentech Bets Again on Orionis With $2B+ in Glue Space
22 May 2025 //
BIOSPACE
ChemDiv Marks a Milestone as Orionis` Novel Immunotherapy Enters Ph I Trials
03 Jan 2024 //
PR NEWSWIRE
Orionis Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ORB-011
15 Nov 2023 //
BUSINESSWIRE
Orionis Biosciences Announces Collaboration with Genentech
20 Sep 2023 //
BUSINESSWIRE
Orionis Presents Data on Interferon and IL-2 Targeted Cytokine Immunotherapies
14 Nov 2022 //
BUSINESSWIRE